Development of nucleic acid medicines based on chemical technology
Y Kawamoto, Y Wu, Y Takahashi, Y Takakura - Advanced Drug Delivery …, 2023 - Elsevier
Oligonucleotide-based therapeutics have attracted attention as an emerging modality that
includes the modulation of genes and their binding proteins related to diseases, allowing us …
includes the modulation of genes and their binding proteins related to diseases, allowing us …
Development of Nucleic Acid Medicines Based on Chemical Technology.
Y Kawamoto, Y Wu, Y Takahashi… - Advanced Drug Delivery …, 2023 - europepmc.org
Oligonucleotide-based therapeutics have attracted attention as an emerging modality that
includes the modulation of genes and their binding proteins related to diseases, allowing us …
includes the modulation of genes and their binding proteins related to diseases, allowing us …
[引用][C] Development of nucleic acid medicines based on chemical technology
Y Kawamoto, Y Wu, Y Takahashi… - Advanced Drug Delivery …, 2023 - cir.nii.ac.jp
Development of nucleic acid medicines based on chemical technology | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Development of Nucleic Acid Medicines Based on Chemical Technology
Y Kawamoto, Y Wu, Y Takahashi… - Advanced drug delivery … - pubmed.ncbi.nlm.nih.gov
Oligonucleotide-based therapeutics have attracted attention as an emerging modality that
includes the modulation of genes and their binding proteins related to diseases, allowing us …
includes the modulation of genes and their binding proteins related to diseases, allowing us …